Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational study

被引:7
|
作者
Rogowski, Paul [1 ]
Schoenecker, Stephan [1 ]
Pazos, Montserrat [1 ]
Reitz, Daniel [1 ]
Braun, Michael [2 ]
Poelcher, Martin [2 ]
Hanusch, Claus [2 ]
Wuerstlein, Rachel [3 ,4 ]
Harbeck, Nadia [3 ,4 ]
Mahner, Sven [3 ,4 ]
Belka, Claus [1 ,4 ]
Corradini, Stefanie [1 ]
机构
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiat Oncol, Marchioninistr 15, D-81377 Munich, Germany
[2] Red Cross Breast Ctr, Taxisstr 3, D-80637 Munich, Germany
[3] Ludwig Maximilians Univ Munchen, Dept Obstet & Gynecol, Breast Ctr, Marchioninistr 15, D-81377 Munich, Germany
[4] Ludwig Maximilians Univ Munchen, Univ Hosp, Comprehens Canc Ctr CCC LMU, Marchioninistr 15, D-81377 Munich, Germany
关键词
Male breast cancer; Radiotherapy; Local control; Survival; Observational study; Outcome; POSTMASTECTOMY RADIATION-THERAPY; POPULATION; SURVIVAL; MANAGEMENT; DIAGNOSIS; OUTCOMES; SURGERY; IMPACT; MEN;
D O I
10.1007/s00066-018-1337-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purposeDue to the rarity of male breast cancer (male BC), no consensus has been reached regarding the most appropriate curative treatment strategy. The objective of the present observational study was to identify patient and tumor characteristics and assess the role of radiotherapy (RT) in clinical practice.MethodsBetween 1998 and 2014, data of male BC patients treated at two breast centers were consecutively collected and retrospectively analyzed. Patients were stratified based on the addition of adjuvant RT. Data on overall survival (OS) and local recurrence-free survival (LRFS) were estimated with the Kaplan-Meier method and compared by the log-rank test.ResultsAconsecutive cohort of 58male BC patients was evaluated. Median follow-up was 56months. Twenty-one patients (36.2%) received adjuvant RT. Overall, patients undergoing postoperative RT were characterized by more high-risk features. Patients receiving postoperative RT had significantly more frequently ahigh UICC stage (50 vs. 9.7% UICCIII, p=0.018) and positive lymph nodes as compared to patients undergoing surgery alone (65 vs. 34.4% pN+, p=0.046). Accordingly, there was ahigher proportion of patients receiving axillary lymph node dissection in the RT group (71.4 vs. 35.6%). Mastectomy was performed in 31/37 (86.1%) in the surgery group as compared to 14/21 (66.7%) in patients receiving postoperative RT. In addition, RT patients were more likely to receive endocrine therapy (78.9 vs. 39.3%, p=0.016). Outcome was not significantly different between the groups (5-year LRFS: 89.8 vs. 80.0%, p=0.471 and 5-year OS 88.4 vs. 88.9%, p=0.819).ConclusionThe present observational study evaluated the pattern of care in male BC patients treated in clinical practice. Due to its rarity, randomized clinical trials are unlikely and male BC remains an entity with apoor evidence base. Nevertheless, RT remains acrucial component of the multidisciplinary treatment strategy in male BC.
引用
收藏
页码:289 / 296
页数:8
相关论文
共 50 条
  • [1] Adjuvant Radiotherapy in male Breast Cancer Patients in clinical Practice: An Observational Study
    Rogowski, P.
    Pazos, M.
    Schoenecker, S.
    Reitz, D.
    Braun, M.
    Harbeck, N.
    Engel, J.
    Belka, C.
    Corradini, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S143 - S144
  • [2] The role of adjuvant radiotherapy in male breast cancer patients in clinical practice
    Rogowski, P.
    Pazos, M.
    Schoenecker, S.
    Reitz, D.
    Braun, M.
    Harbeck, N.
    Engel, J.
    Belka, C.
    Corradini, S.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S731 - S731
  • [3] Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational studyAdjuvante Radiotherapie beim Mammakarzinom des Mannes in der klinischen Praxis: Eine Beobachtungsstudie
    Paul Rogowski
    Stephan Schönecker
    Montserrat Pazos
    Daniel Reitz
    Michael Braun
    Martin Pölcher
    Claus Hanusch
    Rachel Wuerstlein
    Nadia Harbeck
    Sven Mahner
    Claus Belka
    Stefanie Corradini
    Strahlentherapie und Onkologie, 2019, 195 : 289 - 296
  • [4] Adjuvant radiotherapy in male breast cancer
    Stranzl, H
    Mayer, R
    Quehenberger, F
    Prettenhofer, U
    Willfurth, P
    Stöger, H
    Hackl, A
    RADIOTHERAPY AND ONCOLOGY, 1999, 53 (01) : 29 - 35
  • [5] PATTERN OF CARE STUDY OF BREAST-CANCER ADJUVANT CHEMOTHERAPY
    GOLDSMITH, MA
    GREENSPAN, EM
    SILVERMAN, J
    CANCER INVESTIGATION, 1986, 4 (05) : 497 - 498
  • [6] Are international guidelines on adjuvant treatment for early breast cancer followed in clinical practice? A multicenter observational study on 1547 patients treated in 1997
    Palazzi, M
    Asnaghi, D
    Baroncelli, G
    Cavallini, D
    De Tomasi, D
    Guzzetti, R
    Meregalli, S
    Morrica, B
    Pradella, R
    Valli, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S229 - S229
  • [7] Fatigue in patients with breast cancer before and in the process of adjuvant radiotherapy -: A clinical-internal study with 80 patients
    Steingraeber, M.
    Feyer, P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 129 - 129
  • [8] Adjuvant Radiotherapy for Male Breast Carcinoma
    Aytas, F. Ilknur
    Habiboglu, Rahsan
    Sayan, Haluk
    Cetinyokus, Ferit
    Cakar, Salih Z.
    Aslan, Nalan
    EUROPEAN JOURNAL OF GENERAL MEDICINE, 2012, 9 (03): : 170 - 172
  • [9] Pattern of care of radiotherapy practice for EBRT patients in Spain
    Defourny, N.
    Medina, A. L.
    Tarjuelo, J. L.
    Rodriguez, A.
    Giralt, J.
    Novais, J. C.
    Martin, M. M.
    Luis, A. M.
    Isern, J.
    Lopez, I. H.
    Leaman, O.
    Arias De la Vega, F.
    Morera, R.
    Cerezo, L.
    Campos, F. L.
    Rodriguez, S.
    Conde Moreno, A. J.
    Lozano Borbalas, A.
    Rodriguez de Dios, N.
    Rodriguez-Ruiz, M. E.
    Lara, P. C.
    Ferrer, C.
    Borras, J. M.
    Grau, C.
    Lievens, Y.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S316 - S317
  • [10] Hypofractionated adjuvant Radiotherapy in elderly Patients with Breast cancer
    Piefel, K.
    Schneider, T.
    Soeger, S.
    Glessmer, S.
    Bislich, O.
    Seegenschmiedt, M. H.
    Fehlauer, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 81 - 81